Essa Pharma Inc Net Income per Employee (EPIX), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Essa Pharma inc   (NASDAQ: EPIX)
 

Essa Pharma Inc Net Income per Employee

EPIX's Quarterly Results, Trends, Rankings, Statistics
Essa Pharma Inc recorded a cumulative net loss of $-25 million during 12 month ending in the third quarter 2025.
The Healthcare sector has seen employees of 320 other companies achieving higher income per employee. While Essa Pharma Inc 's total ranking has deteriorated compared to the previous quarter from 3333 to 4128.


What is Income per Employee Ratio?






EPIX Net Income per Employee (Jun 30 2025)
III. Quarter
(Mar 31 2025)
II. Quarter
(Dec 31 2024)
I. Quarter
(Sep 30 2024)
IV. Quarter
(Jun 30 2024)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,403,623 -1,583,093 -1,728,357 -1,585,712 -1,537,164
EPIX's Total Ranking # 4128 # 3333 # 3805 # 3123 # 2373
Seq. Net Income Change - - - - -


EPIX Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 321
Healthcare Sector # 748
Overall Market # 4128

Net Income per Employee Statistics
High Average Low
$ -646,080 $ -1,842,319 $ -3,347,268
(Sep 30 2018)   (Sep 30 2021)







Companies with similar Income per Employee for 12 month ending Jun 30 2025, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2025Number of Employees Jun 30 2025


Date modified: 2026-09-08T17:33:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.